180 Life Sciences Stock Cash Flow From Operations
| ATNF Stock | USD 2.13 0.16 6.99% |
Fundamental analysis of 180 Life allows traders to better anticipate movements in 180 Life's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. 180 Life Sciences Company Cash Flow From Operations Analysis
180 Life's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current 180 Life Cash Flow From Operations | (1.48 M) |
Most of 180 Life's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 180 Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, 180 Life Sciences has (1.48 Million) in Cash Flow From Operations. This is 100.28% lower than that of the Biotechnology sector and 102.37% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 100.15% higher than that of the company.
180 Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 180 Life's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 180 Life could also be used in its relative valuation, which is a method of valuing 180 Life by comparing valuation metrics of similar companies.180 Life is currently under evaluation in cash flow from operations category among its peers.
180 Fundamentals
| Return On Equity | -2.21 | ||||
| Return On Asset | -0.55 | ||||
| Current Valuation | 10.26 M | ||||
| Shares Outstanding | 6.04 M | ||||
| Shares Owned By Insiders | 62.83 % | ||||
| Shares Owned By Institutions | 9.79 % | ||||
| Number Of Shares Shorted | 64.24 K | ||||
| Price To Earning | 0.63 X | ||||
| Price To Book | 1.79 X | ||||
| EBITDA | (6.32 M) | ||||
| Net Income | (6.17 M) | ||||
| Cash And Equivalents | 1.63 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 154.5 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 0.67 X | ||||
| Book Value Per Share | 1.49 X | ||||
| Cash Flow From Operations | (1.48 M) | ||||
| Short Ratio | 1.79 X | ||||
| Earnings Per Share | (14.48) X | ||||
| Target Price | 80.0 | ||||
| Number Of Employees | 13 | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 13.83 M | ||||
| Total Asset | 12.76 M | ||||
| Retained Earnings | (141.52 M) | ||||
| Working Capital | 1.64 M | ||||
| Net Asset | 12.76 M |
About 180 Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 180 Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 180 Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 180 Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp | |
| BTE | Baytex Energy Corp | |
| SOXS | Direxion Daily Semiconductor |
Check out 180 Life Piotroski F Score and 180 Life Altman Z Score analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.